Dear readers, a recent IPO debutant, ClearBridge stock closed the trading day yesterday at $0.27, which is around 3.6% down from its IPO price of $0.28. As you may be aware, ClearBridge IPO is not open to retail investors and hence investors who are interested in this stock could just buy it off the open stocks markets. I read the prospectus of ClearBridge briefly during its IPO and understood that it is an investment holding company, which offers laboratory testing services and lifestyle and wellness management testing services. In addition, ClearBridge owns and operates two medical clinics/centers; and invests in precision medical technology companies. There is nothing really striking about its business except for one highlight which is that the company is helmed by Mr Jeremy Yee, the former CEO of CordLife who stepped down from CordLife (see related article here ) . But unlike CordLife which has ......